US Map / Virginia
State VA

Clinical Trials in Virginia

Virginia is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Virginia and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.

Right now ClinicalMetric tracks 282 actively recruiting studies with Virginia sites out of 282 registered in total. The busiest research areas in Virginia are Breast Cancer, Colorectal Cancer, Endometrial Cancer. Leading sponsors running trials in the state include National Cancer Institute (NCI), University of Virginia, Virginia Commonwealth University. By stage, Virginia trials break down as Phase 1 (60), Phase 2 (93), Phase 3 (86), Phase 4 (9).

All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.

Total Trials
282
Recruiting Now
282
← Back to US Map
Top Conditions in Virginia
Breast Cancer (15)Colorectal Cancer (10)Endometrial Cancer (9)Ovarian Cancer (8)Acute Myeloid Leukemia (7)Non-Small Cell Lung Cancer (7)Advanced Solid Tumor (6)Non-small Cell Lung Cancer (6)Prostate Cancer (5)Metastatic Breast Cancer (4)NSCLC (4)Obesity (3)

Frequently Asked Questions — Clinical Trials in Virginia

How many clinical trials are currently recruiting in Virginia?
ClinicalMetric currently tracks 282 actively recruiting clinical trials with at least one location in Virginia. The total number of registered studies—including active but not currently enrolling trials—is 282. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Virginia?
Virginia hosts clinical trials across a broad range of medical conditions, including Breast Cancer, Colorectal Cancer, Endometrial Cancer, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Virginia serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Virginia?
To join a clinical trial in Virginia, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Virginia maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Virginia

NCT05775523 N/A
Recruiting
A Post-Authorisation Safety Study (PASS) of Patients Treated With Lonapegsomatro...
Condition
Growth Hormone Deficiency
Enrollment
500 pts
Location
United States
Sponsor
Ascendis Pharma Endocrinology
View Trial →
NCT05424003 Phase 2
Recruiting
Randomized Double Blinded Placebo-Controlled w/Semaglutide to Prevent Weight Gai...
Condition
NAFLD
Enrollment
50 pts
Location
United States
Sponsor
University of Virginia
View Trial →
NCT07361562 Phase 1
Recruiting
A Study of a Selective ERBB2 Inhibitor (CGT4255), in Patients With Advanced Soli...
Condition
Advanced Solid Tumor, Adult
Enrollment
100 pts
Location
United States
Sponsor
Cogent Biosciences, Inc.
View Trial →
NCT07128303 Phase 1
Recruiting
Study of GS-5319 in Adults With Solid Tumors
Condition
Advanced Solid Tumor
Enrollment
178 pts
Location
United States, South Korea, Spain
Sponsor
Gilead Sciences
View Trial →
NCT06292117 N/A
Recruiting
Implementation of Onsite Rapid CYP2C19 Assay for Genotype Guided Dual Antiplatel...
Condition
Ischemic Stroke
Enrollment
350 pts
Location
United States
Sponsor
University of Virginia
View Trial →
NCT05843318 N/A
Recruiting
Water Intake and Weight Control in Older Adults
Condition
Overweight and Obesity
Enrollment
375 pts
Location
United States
Sponsor
Virginia Polytechnic Institute
View Trial →
NCT06172296 Phase 3
Recruiting
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Tre...
Condition
Ganglioneuroblastoma, Nodular
Enrollment
478 pts
Location
United States, Australia, Canada
Sponsor
National Cancer Institute (NCI
View Trial →
NCT07312903 Phase 1
Recruiting
DPTX3186 in Wnt Pathway Activated Solid Tumors
Condition
Solid Tumors
Enrollment
40 pts
Location
United States
Sponsor
Dewpoint Therapeutics
View Trial →
NCT06350097 Phase 3
Recruiting
Phase III, Open-label Study of First-line Osimertinib With or Without Datopotama...
Condition
Non-small Cell Lung Cancer
Enrollment
582 pts
Location
United States, Australia, Brazil
Sponsor
AstraZeneca
View Trial →
NCT06776783 Phase 3
Recruiting
Safety and Efficacy of APC-0101 in Preterm Infants With Respiratory Distress Syn...
Condition
Respiratory Distress Syndrome
Enrollment
520 pts
Location
United States
Sponsor
Aerogen Pharma Limited
View Trial →
NCT05883241 Phase 1
Recruiting
Sustained Acoustic Medicine (SAM) for Symptomatic Treatment of Pain Related to B...
Condition
Bone Fracture
Enrollment
90 pts
Location
United States
Sponsor
ZetrOZ, Inc.
View Trial →
NCT06158841 Phase 3
Recruiting
Study Assessing Activity of Intravenous (IV) Etentamig Monotherapy Versus Standa...
Condition
Multiple Myeloma
Enrollment
380 pts
Location
United States, Australia, Austria
Sponsor
AbbVie
View Trial →
NCT06672146 Phase 2
Recruiting
Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia ...
Condition
Acute Myeloid Leukemia
Enrollment
93 pts
Location
United States, Puerto Rico
Sponsor
National Cancer Institute (NCI
View Trial →
NCT05489588 N/A
Recruiting
The GORE® VIABAHN® FORTEGRA Venous Stent Iliofemoral Study
Condition
Venous Thromboses
Enrollment
165 pts
Location
United States
Sponsor
W.L.Gore & Associates
View Trial →
NCT05711394 Phase 3
Recruiting
A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atog...
Condition
Episodic Migraine
Enrollment
450 pts
Location
United States, Belgium, Canada
Sponsor
AbbVie
View Trial →
NCT04994756 N/A
Recruiting
Stroke Thrombectomy and Aneurysm Registry
Condition
Stroke
Enrollment
40,000 pts
Location
United States, Canada, Germany
Sponsor
Medical University of South Ca
View Trial →
NCT04566328 Phase 3
Recruiting
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Mu...
Condition
Plasma Cell Myeloma
Enrollment
1,450 pts
Location
United States, Puerto Rico
Sponsor
ECOG-ACRIN Cancer Research Gro
View Trial →
NCT05147792 N/A
Recruiting
The CONFORM Pivotal Trial
Condition
Atrial Fibrillation
Enrollment
1,600 pts
Location
United States, Czechia, France
Sponsor
Conformal Medical, Inc
View Trial →
NCT07377331 Phase 1
Recruiting
Exploration of an Online Education Program to Support Caregivers' Knowledge Tran...
Condition
Dementia
Enrollment
60 pts
Location
United States
Sponsor
Texas Christian University
View Trial →
NCT04731961 N/A
Recruiting
Reduction in Number of Botox Injections for Urgency Urinary Incontinence
Condition
Urgency Urinary Incontinence
Enrollment
56 pts
Location
United States
Sponsor
University of Virginia
View Trial →
NCT07661056 Phase 3
Recruiting
Study to Determine if BHV-1300 is Effective and Safe in Adults With Graves' Dise...
Condition
Graves Disease
Enrollment
300 pts
Location
United States
Sponsor
Biohaven Therapeutics Ltd.
View Trial →
NCT07173751 Phase 3
Recruiting
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-N...
Condition
Breast Neoplasms
Enrollment
558 pts
Location
United States, Australia, Belgium
Sponsor
BioNTech SE
View Trial →
NCT07011719 Phase 3
Recruiting
Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients...
Condition
Metastatic Clear Cell Renal Cell Carcinoma
Enrollment
720 pts
Location
United States, Australia, Canada
Sponsor
Arcus Biosciences, Inc.
View Trial →
NCT05580419 N/A
Recruiting
Impact of 4PCP on Practitioner and Patient Outcomes
Condition
Chronic Pain
Enrollment
1,188 pts
Location
United States
Sponsor
Virginia Commonwealth Universi
View Trial →
NCT07356453 Phase 1
Recruiting
A Study of PARG Inhibitor FORX-428 in Patients With Advanced Solid Tumors.
Condition
Advanced Solid Tumors
Enrollment
40 pts
Location
United States
Sponsor
FoRx Therapeutics AG
View Trial →
Page 3 of 12 — 282 trials total
← Prev Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology